Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1995 Jul;79(7):642-5.
doi: 10.1136/bjo.79.7.642.

Continuous wave Nd:YAG laser photocoagulation in proliferative diabetic retinopathy

U Menchini  1 , P Lanzetta, F Soldano, E Ferrari, G Virgili
Affiliations
Clinical Trial

Continuous wave Nd:YAG laser photocoagulation in proliferative diabetic retinopathy

U Menchini et al. Br J Ophthalmol. 1995 Jul.

Abstract

Aims: The therapeutic efficacy of the continuous wave (CW) Nd:YAG laser (working in the free running mode) was investigated in proliferative diabetic retinopathy (PDR) comparing it with a conventional laser source such as the krypton laser.

Methods: Twenty four eyes of 12 patients affected with bilateral PDR were included and divided in two groups. The right eyes were treated with a red krypton laser and the left eyes with a CW Nd:YAG laser.

Results: Three months after krypton photocoagulation 10 eyes showed a reduction or a complete regression of PDR and two eyes were unchanged. In the CW Nd:YAG laser group no eyes showed any regression of new vessels, in seven eyes the angiographic features were unchanged, and in five eyes they worsened. All the eyes of the second group underwent retreatment with the krypton laser after 3 or 6 months. After a mean follow up of 13 months all eyes in the krypton group showed a reduction or complete regression of PDR; in the retreated group 10 eyes improved and two were unchanged.

Conclusions: The statistical analysis showed a highly significant difference (p = 0.001) between krypton and CW Nd:YAG laser which indicated the lack of efficacy of the latter in the treatment of PDR. In the krypton laser group no significant difference (p = 0.05) after the retreatment was found confirming the efficacy of this treatment.

PubMed Disclaimer

References

    1. Ophthalmic Surg. 1990 Apr;21(4):258-62 - PubMed
    1. Am J Ophthalmol. 1956 Dec;42(6):907-10 - PubMed
    1. Arch Ophthalmol. 1972 Jun;87(6):693-700 - PubMed
    1. Eye (Lond). 1989;3 ( Pt 5):516-27 - PubMed
    1. Trans Am Ophthalmol Soc. 1986;84:967-1003 - PubMed